Title:
ANTI-HUMAN GROWTH HORMONE SINGLE-DOMAIN ANTIBODY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/231888
Kind Code:
A1
Abstract:
The present invention relates to a single-domain antibody or an antigen-binding fragment thereof specifically binding to human growth hormone, a conjugate containing the single-domain antibody or the antigen-binding fragment thereof, a nucleic acid molecule encoding the single-domain antibody or the antigen-binding fragment thereof and a host cell containing same, and the related use thereof. In addition, the present invention relates to the use of the conjugate in the detection or purification of human growth hormone.
Inventors:
WANG SIQIN (CN)
LIANG YANGQIU (CN)
LIU YANSHUANG (CN)
LIU XIAOHUI (CN)
LIU SHUANG (CN)
ZHANG RUI (CN)
ZONG YI (CN)
WANG TAO (CN)
JIN LEI (CN)
LIANG YANGQIU (CN)
LIU YANSHUANG (CN)
LIU XIAOHUI (CN)
LIU SHUANG (CN)
ZHANG RUI (CN)
ZONG YI (CN)
WANG TAO (CN)
JIN LEI (CN)
Application Number:
PCT/CN2023/096259
Publication Date:
December 07, 2023
Filing Date:
May 25, 2023
Export Citation:
Assignee:
CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/26; C07K14/61; C07K19/00; C12N15/70; C12P21/08; G01N33/53
Foreign References:
| CN112362649A | 2021-02-12 | |||
| CN114478766A | 2022-05-13 | |||
| CN1180107A | 1998-04-29 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF:
Previous Patent: TENSOR-BASED CONTINUAL LEARNING METHOD AND DEVICE
Next Patent: ANTIBODY CONJUGATE AND USE THEREOF
Next Patent: ANTIBODY CONJUGATE AND USE THEREOF